216. Clinicopathological data and predictors of PR and HER2neu positivity prior to biopsy in advanced female breast cancer, NCI experience. Issue 9 (September 2016) - Rahouma, M.; Abou El-Kasem, F.; Aziz, H.; Loay, I.